{"id":14,"date":"2025-10-14T14:03:21","date_gmt":"2025-10-14T14:03:21","guid":{"rendered":"https:\/\/mattersgraph.com\/?page_id=14"},"modified":"2026-06-16T12:02:47","modified_gmt":"2026-06-16T16:02:47","slug":"private-equity","status":"publish","type":"page","link":"https:\/\/mattersgraph.com\/zh\/private-equity\/","title":{"rendered":"Private Equity"},"content":{"rendered":"
<\/div>
\n

Commercial Diligence for Private Equity <\/span><\/h2>\n\n

Buy-Side-Only Commercial Diligence Built for the Exit, Not Just the Checkpoints<\/span><\/h3>\n\n

The deals that damage a fund are rarely the ones you lose. They are the ones you win on a commercial thesis that was never pressure tested against ground truth.<\/p>\n\n

The investors who move with conviction are the ones whose diligence gave them something the other bidders didn’t have: a clear view of what is actually true about the market, the customers, and the competitors who will shape the hold.<\/p>\n\n

That clarity is not a deliverable filed at IC. It is a continuous evidence base, built and refreshed to one bar, that sharpens the entry, arms the operating team with the customer evidence the value-creation plan needs through the hold, and stands behind the exit when the next buyer’s diligence tests it. Matters Graph builds commercial intelligence to that bar. The work is the diligence that produces real and critical learning, not filler.<\/p>\n\n

Diligence that produces real and critical learning, not filler.<\/p><\/blockquote>\n<\/div><\/div>\n\n

\n

Effectiveness Over Efficiency<\/strong><\/strong><\/span><\/h3>

Banker timelines and bid competition have made speed the default. Speed without effectiveness funds the wrong thesis. Timelines deserve respect. Rigor earns the ROI.<\/p><\/div><\/div>\n\n

Diligence that Carries to Exit<\/strong><\/strong><\/span><\/h3>

Diligence built to clear IC rarely carries past it. The evidence that justified the entry should anchor the operating plan, sharpen the value-creation roadmap, and stand behind the exit narrative the next buyer’s diligence will test.<\/p><\/div><\/div>\n\n

Built to Crack the Case<\/strong><\/strong><\/span><\/h3>

The discipline is one thing: find what is actually true about the market, the customers, the target, and the competitors, then present it plainly enough to stake capital on.<\/p><\/div><\/div>\n<\/div><\/div>\n\n

Buy Side Only<\/strong><\/span><\/h2>\n\n

Matters Graph practices commercial diligence only on the buy side because that is the discipline our work is built to do well. Investigating a thesis to ground truth, on a timeline a deal team can use, with conclusions that hold up at IC and continue to hold up across the hold, is a different practice from the one a sell-side mandate calls for. Buyers paying premium prices need diligence built specifically for that work, and that is the work we do, and the work that buy-side decision makers have learned to trust.<\/strong><\/p>\n\n

Building sell-side decks and answering the questions that determine deal outcomes require different disciplines: different instincts, different standards of evidence, different tolerances for inconvenient findings. A firm that practices both inevitably optimizes for the one that is easier to sell. The buy side is best served by a firm whose entire practice is oriented toward finding what is true, not what is flattering.<\/p>\n\n

Matters Graph was founded in 2017 on a single premise: that investors making acquisitions and building value creation plans deserve a diligence partner whose only job is to tell them what is true. Built on a quarter-century of buy-side commercial diligence practice, across market cycles, sector rotations, and the full range of sponsor strategies, that premise has not changed, and it will not. Every project, every interview, every finding is subject to the same test: would this hold up in front of the Investment Committee of a firm that paid a premium to win the deal? The work is first-principles and grounded in rigorous customer understanding, not the recycled theses and borrowed opinions that expert networks package as insight. What matters is not what happened last quarter; it is what is likely to play out over the next five years.<\/p>\n\n

Pre-Empt vs. Process Dependent<\/span><\/h2>\n\n

Some of the strongest-performing deals in private equity have something in common: they never had a real process. The sponsor developed a proprietary thesis over months or years, approached the target directly with a commercial view the banker-led bidders would not have for another six months, and won the deal at a price the process would not have supported. Pre-empting is not a tactic. It is a capability built from sustained commercial intelligence. That same intelligence sharpens the entry, arms the operating team through the hold, and stands behind the exit when the next buyer’s diligence tests it.<\/p>\n\n

Pre-empting requires knowing what the process-run bidders may eventually find, before they start looking.<\/p><\/blockquote>\n\n

The difference between a sponsor who pre-empts successfully and one who doesn’t is conviction.<\/strong><\/p>\n\n

Specifically, it’s conviction based on commercial evidence the other bidders don’t yet have: a view of the target’s customer base, a read on competitive dynamics, a quantified sense of remaining growth headroom. Pre-empting requires knowing what the process-run bidders may eventually find, before they start looking. That’s a specific commercial-diligence problem, and it’s different from transaction-CDD work on a live process.<\/p>\n\n

Matters Graph runs pre-process commercial diligence as its own discipline. Sector-level and sub-sector-level evidence is developed and refreshed across multiple potential targets before any one is live. Deal teams iterate thesis refinement with the primary-research data as it is collected, rather than receiving a single report at the end of a compressed window. The work produces both the conviction to pre-empt on a given target and the evidence base that is already largely built when, inevitably, one of the targets does go to process. Sponsors who engage this way do not start transaction diligence from zero; they start from a commercial understanding most of the bidder field will not catch up to.<\/p><\/div>\n\n

Thesis-Driven Diligence <\/strong><\/strong><\/span><\/h2>\n\n

Active investing begins with an original thesis. Without one, an underwriting is indistinguishable from every other bidder’s, and there’s no defensible basis for the premium required to win. The thesis is also the frame that every finding compounds on. <\/strong>The operating plan executes against it, and the next buyer’s diligence tests it. Commercial diligence should sharpen the thesis, not validate a generic one supplied by the banker’s book, the sell-side narrative, or the sector consensus every other bidder is also chasing. Premium deals are rarely won on consensus.<\/p>\n\n

Every engagement begins with a thesis, whether the deal team brings it, develops it jointly, or refines one drawn from customer evidence, and subjects it to customer-sourced investigation. Narrowly scoped, staged exercises that resolve the next critical question are more useful to a deal team than a single monolithic study that arrives after the window has closed. Diligence should move with the decision, not behind it. <\/p>\n\n

The thesis is not just where the diligence starts. It is the organizing spine of every page that follows. Every chapter of a Matters Graph deliverable answers a question the thesis raised; every finding earns its place by informing an investment decision the deal team is actually making. Work product built this way is shorter than the industry norm. It is also more useful: the deal team can read it once, route it to the IC, and cite it in the memo. Every page earns its place. Peripheral context, competitive snapshots that don’t bear on the thesis, and market maps that pad page count don’t make it into the work product. If a chapter doesn’t inform a decision the deal team is making, it doesn’t belong.<\/p>\n\n

Investigators Who Seek Out the Critical Nuance<\/strong><\/span><\/h2>\n\n

Customer conviction, prospect hesitation, a competitor’s customer explaining why they stayed or switched: these signals live in tone, pause, and phrasing, and they are lost in the handoff from interviewer to synthesizer to presenter. The standard<\/em> model that our industry relies on uses too few interviews, expert networks in place of the target’s actual customers, and findings packaged into a polished but false narrative. That is how critical nuance disappears before it reaches the Investment Committee.<\/strong><\/p>\n\n

At Matters Graph, the people presenting to the investment team are the people who conducted the research. When the room needs to distinguish signal from story, the briefer should be the one who found the signal.<\/p>\n\n

Evidence That Holds Up Under Scrutiny: First Principles<\/span><\/h2>\n\n

Every acquisition thesis is, at its core, a bet on customers. <\/strong>The experts that matter for a buy-side commercial question are the customers, the lost customers, the non-users who should be customers but aren’t, competitors’ customers, and the channel buyers and influencers who shape purchasing decisions. The evidence that matters is gathered from them, at scale, under conditions built to hold up. Consulting firms typically compete on heritage brand and broad biography: qualifications, industry veterans, and prior diligence on adjacent assets. They too often sell conclusions derived from that experience or repurposed from earlier assets in the sector. The answers to buy-side commercial questions are not in the advisor’s head. They are in the market, waiting to be collected, and reached only by thesis-driven primary research that builds conclusions from the ground up.<\/p>\n\n

When primary research is conducted, it is too often sourced through expert networks whose respondents are drawn from the network’s database without verified relevance to the target’s actual buyers, users, or decision-making process, rather than custom-sourced by those responsible for cracking the case: current users, prospective buyers with the problem the product solves, the influencers and decision-makers involved in the purchase, lost customers, competitors’ customers, and the channel participants who shape which options reach the decision-maker. In most markets, the purchase itself is cross-functional and jointly made, which means the research has to reach the full decision-making group, not just the budget holder. Expert networks match firms with individuals who have indicated some connection to the relevant industry, but there is limited structural verification that their experience maps to the buying behavior the thesis depends on. The first few calls may surface someone genuinely relevant; beyond that, relevance declines because the network’s business model rewards completed calls, not respondent quality. The result is a set of responses that sound informed but carry no verifiable connection to the decisions the thesis depends on. When consulting firms use these calls as source material and present curated quotes in a deck, the provenance is invisible to the IC. What remains are quotes that support the narrative, not a representative read of customers, lost customers, non-users, channel participants, and the decision-makers whose behavior the model underwrites.<\/p>\n\n\n\n

High-N Research Drives Distinctive Insights<\/strong><\/span><\/h2>\n\n

Underwriting a premium bid requires statistical confidence small-sample research cannot deliver. A handful of customer calls can tell a story; they cannot confirm whether that story holds across the target’s full addressable market. The commercial assumptions behind a premium bid need to hold up at scale, not anecdotally. A low-N study with customer quotes in the deck can look like that test was conducted. It is not the same as conducting it. High-sample-size, custom-sourced Voice of Customer and Voice of Channel research is how commercial assumptions actually get tested.<\/p><\/div>\n\n

\n

The hidden churn segment<\/strong><\/strong><\/span><\/h3>

Aggregate retention reads 93%. At high N, a behavioral segment \u2014 customers acquired through channel partners rather than direct \u2014 churns at two to three times the average rate. A small-sample study sees the 93% and moves on. The risk is that the growth plan leans into channel, and the blended retention rate degrades as the mix shifts.<\/p><\/div><\/div>\n\n

The pricing ceiling management doesn’t mention<\/strong><\/strong><\/span><\/h3>

Management says there is 15\u201320% pricing headroom. Most customers confirm they value the product. But willingness to pay only separates from satisfaction at high N, when you can segment by size, use case, and competitive alternatives. At scale, the headroom exists for one segment and is near zero for another that represents 40% of revenue.<\/p><\/div><\/div>\n\n

The competitive displacement that hasn’t hit win\/loss yet<\/strong><\/strong><\/span><\/h3>

A new entrant is taking share, but a small-sample study catches one or two mentions and cannot distinguish signal from noise. At high N, you can measure awareness and penetration by region and vertical. The competitor has 30% awareness in one vertical and near zero in others. That pattern tells you whether the threat is real and where it will land first.<\/p><\/div><\/div>\n<\/div><\/div>\n\n

In commercial diligence, the point of diminishing returns is at significantly greater scale than what most diligence exercises attempt. A small-sample study can measure an aggregate; it cannot reliably discover behavioral segments, low-incidence high-impact objections, channel-specific dynamics, or lost-deal patterns that drive aggregate outcomes, each often statistically invisible at low N. A customer segment that is 10% of the base but churns at three times the average rate is the kind of risk concentration that decides the thesis, and at a sample size that produces only a handful of observations, the pattern cannot be distinguished from noise. The marginal interview is not redundant; it is often the one that reveals what the earlier interviews could not see. <\/p>\n\n

Behavioral segmentation dictates commercial outcomes far more than demographic segmentation. Behaviors reshape the target’s true Serviceable Addressable Market, often materially, and away from what management presents. Discovering and quantifying them requires sample sizes that small-N studies, the fifteen-to-thirty interview exercises typical of most commercial diligence providers, cannot produce. At the sample sizes we field, multivariate regression and structured survey analytics isolate which behavioral features predict retention, expansion, and churn, turning segment structure from an assertion into a measured input to the underwriting. At twelve times EBITDA on a TAM-supports-the-growth-plan thesis, an oversized SAM assumption is not a modeling risk. It is a capital allocation decision built on the wrong denominator.<\/p>\n\n

An oversized SAM assumption is not a modeling risk. It is a capital allocation decision built on the wrong denominator. <\/p>\n\n

<\/a><\/p><\/blockquote>\n\n

Discover more about our approach<\/i><\/span><\/a><\/div><\/div>\n\n

What We Don’t Do<\/strong><\/strong><\/span><\/h2>\n\n

No sell-side CDD for bankers or sellers.<\/strong> Matters Graph does not produce the vendor due diligence reports that sellers use to market a business to buyers. The firm believes that commercial diligence cannot be as effective coming from the same firm that produces sell-side work; the skeptical posture the buy side requires is incompatible with the promotional discipline sell-side work demands.<\/p>\n\n

The skeptical posture the buy side requires is incompatible with the promotional discipline sell-side work demands.<\/p><\/blockquote>\n\n

No implementation.<\/strong> Matters Graph does not run PMOs, deliver transformations, or serve as interim management. Findings that recommend work the firm can later sell are not findings; they are pitches. Independence between diagnosis and delivery is what makes the commercial conclusions the deal team can use to decide.<\/p>\n\n

No portfolio operations.<\/strong> Matters Graph does not serve as an ongoing operating partner or redesign operating models inside portfolio companies. The firm that sits inside the company next quarter cannot be the firm asking customers hard questions about it this quarter. Independence between advisor and operator is what lets management teams, sponsors, and lenders bring the questions they cannot ask anyone with a stake in the answer.<\/p><\/div>\n\n

Commercial Intelligence Across the Deal Lifecycle<\/strong><\/strong><\/h2>
<\/div>
\n
<\/span>Pre-Process<\/span><\/div>
\n

Thesis work before the book arrives<\/strong><\/p>\n\n

The diligence that matters most often happens before the process. Spend is still discretionary, conviction is still fluid, and a thesis tested against early commercial evidence costs less and decides more than the same test run on a banker’s clock. Targeted commercial investigations at this stage resolve the threshold questions that determine conviction: market size, competitive positioning, customer concentration, and the sustainability of the growth story.<\/p>\n\n

Starting early compounds across the transaction. By the time the book arrives, the deal team is not reading the CIM for the first time; they are testing it against commercial evidence they already hold. Bids become more confident because key uncertainties are already resolved; walk-aways happen earlier, saving process spend on deals that wouldn’t have cleared. For proprietary or pre-emptive opportunities, this is what lets a sponsor approach management as an informed, preferred counterparty rather than one of many reactive bidders. That is how pre-empts actually happen.<\/p>\n<\/div><\/div>\n\n

<\/span>Trans­action<\/strong><\/strong><\/span><\/div>
\n

Depth on the Banker’s Timeline<\/strong><\/p>\n\n

In a live process, the speed-or-depth tradeoff is real but the choice between them is false. Matters Graph CDDs deliver depth on a banker’s timeline because depth at speed requires a research engine built for that constraint, not a methodology stretched to fit it. Investment Committees get the evidence base to act with conviction (market position, competitive dynamics, pricing sustainability, churn and retention drivers, and the commercial assumptions in the model), without sacrificing the depth that separates a defensible underwriting from a hopeful one.<\/p>\n<\/div><\/div>\n\n

<\/span>Post-Close<\/strong><\/strong><\/strong><\/span><\/div>
\n

The Second Objective Begins the Day the Deal Closes<\/strong><\/p>\n\n

Diligence built for IC dies at IC. Diligence built for the hold period compounds across it. Commercial intelligence developed during diligence should carry through the transaction, informing the 100-day plan, setting strategy for the hold period, and setting the value-creation baselines. The evidence that justified the deal is the same evidence the operating plan should build from. For the full scope, see our Value Creation page.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n

Diligence built for IC dies at IC. Diligence built for the hold period compounds across it. <\/p><\/blockquote>\n\n

The Exit Begins at IC<\/span><\/h2>\n\n

Most commercial diligence firms build work product to clear IC, and the evidence inside the work is built to that bar. The anecdotal customer calls, expert-network color, secondary market data, and management-supplied projections that fill standard CDD reports can carry an underwriting through a vote. They cannot carry an operating plan through the hold or stand up to the next buyer’s diligence at exit. The work that wins the IC vote is rarely the work that compounds across ownership.<\/p>\n\n

The deeper failure is one of fellowship. The IC’s real objective isn’t to vote yes today; it’s to not regret this acquisition at exit. Friction at IC over something the exit will turn on is the diligence working, not a problem with it. CDD that produces no friction over anything is a tell\u2014that the work was built to clear a vote, not to inform a partnership that has to live with the consequences. Diligence that takes the IC’s actual objective seriously sometimes makes the vote harder, and that is what makes it worth having.<\/p>\n\n

Matters Graph builds diligence to a different bar: the work the operating team draws on through the hold and the exit team stands behind in the next process. The behavioral segmentation that justified the entry multiple informs the value creation roadmap. The customer-retention drivers that supported the underwriting become the operating metrics management is held to. The pricing elasticity that proved the model anchors the hold-period pricing strategy. The work product is built once, and it compounds across the full ownership.<\/p>\n\n

When the next buyer’s diligence arrives, the commercial claims in the CIM are not assertions the seller hopes will hold up. They are conclusions traceable to evidence collected three years earlier and refined across the hold. That traceability is what separates an exit narrative the next buyer’s CDD confirms from one their CDD has to dismantle.<\/p>\n\n

The IC’s real objective isn’t to vote yes today. It’s to not regret this acquisition at exit. Friction at IC over something the exit will turn on is the diligence working, not a problem with it.<\/p><\/blockquote>\n\n

Our Core Diligence Capabilities<\/span><\/h2>\n\n
\n

Commercial due diligence<\/span><\/h3>

Rigorous, buy-side commercial analysis that pressure-tests your investment thesis: customer-sourced work covering market sizing and growth (TAM, SAM, and the behavioral SAM that actually converts), competitive landscape and positioning, customer segmentation and decision dynamics, retention and churn analysis, unit economics, pricing architecture and elasticity, go-to-market effectiveness, and downside stress-testing of the thesis. Structured to withstand partner-level scrutiny at IC. Delivered on the cadence PE deal teams run: midpoint update, mid-engagement, final calibrated to the IC vote date, and findings built to stand up in that room.<\/p><\/div>

Learn more<\/i><\/span><\/a><\/div><\/div>\n\n

COMMERCIAL OPPORTUNITY ASSESSMENTS<\/span><\/h3>

Targeted pre-process investigations that resolve the threshold questions that decide whether an opportunity is worth pursuing (market size, competitive positioning, customer concentration, and strategic fit), answered through custom-sourced primary research, before a formal process begins and while spend is still discretionary, giving the deal team conviction before capital is committed. The work fits either trigger: a banker-led auction compressing the window, or an organic, proprietary thesis taking shape internally. Scaled to the question, not the process.<\/p><\/div>

Learn more<\/i><\/span><\/a><\/div><\/div>\n\n

PRICING OPTIMIZATION<\/span><\/h3>

Primary-research analysis of willingness-to-pay, price elasticity, and competitive pricing dynamics, using conjoint analysis, Van Westendorp price-sensitivity measurement, and segment-level elasticity modeling, grounded in the customers whose willingness to pay actually sets the ceiling. Identifies the right customers, product mix, and pricing model to maximize profit dollars, showing where a target is leaving value on the table and where model pricing assumptions need adjustment. The same evidence applies across both pricing diligence and post-transaction optimization.<\/p><\/div>

Learn more<\/i><\/span><\/a><\/div><\/div>\n\n

CDD PUBLIC POLICY FACTORS<\/span><\/h3>

Dedicated legislative and regulatory analysis of the policy environment affecting a target: pending rule changes, enforcement trends, and the compliance risks and opportunities that could alter the commercial outlook post-close. Based in Washington, DC, where federal policy is set and the national trade associations sit, whose model legislation states and municipalities adapt, we treat the policy environment as a primary-research problem, custom-sourcing the people whose decisions actually move the question. A rule on the books is not the same as a rule enforced. Reconciled to the investment thesis, not filed as a separate workstream.<\/p><\/div>

Learn more<\/i><\/span><\/a><\/div><\/div>\n\n

Investment Thesis-oriented deliverables<\/span><\/h3>

Work product structured around the investment decision, not consultancy convention. Every chapter answers a question the thesis raised; every finding earns its place by informing a decision the deal team is making, with nothing padding the deck that does not prove out the thesis or make you a smarter owner of the asset. Shorter, sharper, and built to be cited in the IC memo. The bar is not passing muster at IC to get the deal done; it is evidence rigorous enough to anchor the operating plan through the full hold and stand behind the exit when the next buyer’s diligence tests it. Diligence built to clear IC rarely carries past it. This is built to.<\/p><\/div><\/div>\n<\/div><\/div>\n\n

When PE Teams Engage Matters Graph<\/strong><\/span><\/h2>\n\n